Torno Capital »

Cytokinetics shares owned by Torno Capital

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Torno Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 22k 83.49

More positions owned by Torno Capital

Sprott Fds Tr Uranium Miners E Put Option (URNM)
Spotify Technology S A SHS Put Option (SPOT)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Global X Uranium Put Option (URA)
Ishares Msci Sth Kor Etf Put Option (EWY)
Colgate-Palmolive Company Put Option (CL)
Caterpillar Call Option (CAT)
BlackRock Call Option (BLK)
Booz Allen Hamilton Hldg Cor Cl A Call Option (BAH)
United States Stl Corp New Com Put Option (X)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Incyte Corporation Call Option (INCY)
Realty Income Call Option (O)
Rio Tinto Sponsored Adr Call Option (RIO)
Regeneron Pharmaceuticals Put Option (REGN)

View all positions for Torno Capital

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics